American Society of Hirudotherapy

Complete penile amputation during ritual neonatal circumcision and successful replantation using postoperative leech therapy

Banihani OI, Fox JA, Gander BH, Grunwaldt LJ, Cannon GM (2014) · Urology · 1 patient

Case-level evidence: FDA has cleared Hirudo medicinalis as a medical device (K040187, June 21 2004) for venous congestion in surgical flaps. Other uses are off-label or investigational.Study record: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.

Study Profile

Design
single-patient case report (7-day-old neonate, Children's Hospital of Pittsburgh of UPMC)
Patient
1
Presentation and intervention
Microvascular replantation of completely amputated penis at penopubic junction (Mogen clamp injury during circumcision) with postoperative leech therapy
Outcome
First reported neonatal penile amputation replantation with postoperative leech therapy; successful tissue survival with leech-mediated venous decongestion
Follow-up duration
Postoperative hospitalization with subsequent outpatient follow-up

Key Findings

  • First reported neonatal penile leech therapy for replantation
  • Mogen clamp circumcision complication context
  • Successful tissue survival with leech-mediated venous decongestion
  • Penopubic junction amputation level
  • Documents US K040187 application in 7-day-old patient

Limitations

  • Single case - no generalizable conclusions
  • Limited long-term follow-up reporting
  • Functional outcomes uncertain at age 7 days
  • Cannot quantify leech vs surgical contribution
  • Extreme age limits protocol transfer

Clinical Implications

Banihani 2014 documents the youngest reported leech therapy patient in penile replantation literature. For US clinicians under K040187, the case demonstrates feasibility of the device indication in neonates but raises proportional dose/duration questions. The Mogen clamp circumcision complication context highlights leech therapy's role in iatrogenic injury salvage.

Related studies

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.